References
- Oscar A-C. Basic mechanisms of rTMS: implications in Parkinson’s disease. Int Arch Med. 2008;1:2.
- Wu AD, Fregni F, Simon DK, et al. Noninvasive brain stimulation for Parkinson’s disease and dystonia. Neurotherapeutics. 2008;5(2):345–361.
- Zwanzger P, Ella R, Keck ME, et al. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry. 2002;51(7):602–603.
- Bentwich J, Dobronevsky E, Aichenbaum S, et al. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study. J Neural Transm. 2011;118(3):463–471.
- Fitzgerald PB, Daskalakis ZJ. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev Med Devices. 2011;8(1):85–95.
- Cotelli M, Manenti R, Cappa SF, et al. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol. 2008;15(12):1286–1292.
- Cotelli M, Calabria M, Manenti R, et al. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry. 2011;82:794–797.
- Lazzaro VD, Dileone M, Pilato F, et al. Repetitive transcranial magnetic stimulation for ALS: a preliminary controlled study. Neurosci Lett. 2006;408:135–140.
- Vincenzo DL, Fabio P, Paolo P, et al. Motor cortex stimulation for ALS: a double blind placebo-controlled study. Neuroence Lett. 2009;464:18–21.
- Lee JY, Kim SH, Ko AR, et al. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson’s disease. Brain Res. 2013;1537:290–302.
- Ba F, Zhou Y, Zhou J, et al. Repetitive transcranial magnetic stimulation protects mice against 6-OHDA-induced Parkinson’s disease symptoms by regulating brain amyloid β1–42 level. Mol Cell Biochem. 2019;458(1–2):71–78.
- Liu H, Li G, Ma C, et al. Repetitive magnetic stimulation promotes the proliferation of neural progenitor cells via modulating the expression of miR-106b. Int J Mol Med. 2018;42(6):3631–3639.
- Song R, Bai Y, Li X, et al. Plasma circular RNA DYM related to major depressive disorder and rapid antidepressant effect treated by visual cortical repetitive transcranial magnetic stimulation. J Affect Disord. 2020;274:486–493.
- Qin C, Jian-Chun YU. Improvement of acupuncture on cognitive function in senescence accelerated mouse P8. Chin J Behav Med Sci. 2005;14:964–965.
- Liu CZ, Yu JC, Cheng HY, et al. Spatial memory performance and hippocampal neuron number in osteoporotic SAMP6 mice. Exp Neurol. 2006;201(2):452–460.
- Yaxing G, Hai L, Lishan Z, et al. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget. 2015;6:37043–37053.
- Kh AA, Filatova EV, Karabanov AV, et al. Potential biomarkers of the earliest clinical stages of Parkinson’s disease. Parkinson’s Dis. 2015;2015:294396.
- Bekris LM, Tsuang DW, Peskind ER, et al. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson’s disease. Mov Disord. 2015;30(7):936–944.